The ARROW® VPS G4™
Device provides accurate and precise PICC placement
LIMERICK, Pa.--(BUSINESS WIRE)--Apr. 29, 2013--
Teleflex Incorporated (NYSE: TFX), a leading global provider of medical
devices for critical care and surgery, announces that its ARROW®
VPS G4™ Device has received 510(k) market clearance from the
U.S. Food and Drug Administration (FDA). The ARROW VPS G4 Device is used
in conjunction with the accompanying disposable ARROW® VPS®
Stylet and will be available in the US in Q2, 2013.
The ARROW VPS Device is the only system to use micro-Doppler ultrasound
technology in combination with intravascular ECG and advanced algorithms
to locate the exact location of the lower 1/3 of the superior vena cava
and cavo-atrial junction – the ideal location for the tip of a PICC. The
technology is designed to provide clinicians real time information,
which can enable avoidance of potentially serious clinical complications
such as thrombosis, arterial puncture and vessel wall damage.
The new ARROW VPS G4 Device offers state-of-the-art design and
technology, providing easy-to-follow symbols with further enhancements
such as statement of final catheter position, improved sterile field
capability, and Wi-Fi access to enable integration with hospital data
management systems.
“There are more than three million PICCs and two million CVCs placed in
the United States each year,” states Paul Molloy, President of the
Vascular Division. “The ARROW VPS G4 Device is a reliable and
easy-to-use system designed to help reduce complications and reduce
patient exposure to radiation. If used on a regular basis, the system
can help streamline hospital workflow, providing benefits to the
patient, the caregiver and the health care system. This new product
introduction complements our full portfolio aimed at making zero
complications in vascular access a reality.”
About Teleflex Incorporated
Teleflex is a leading global provider of specialty medical devices for a
range of procedures in critical care and surgery. Our mission is to
provide solutions that enable healthcare providers to improve outcomes
and enhance patient and provider safety. Headquartered in Limerick, PA,
Teleflex employs approximately 11,600 people worldwide and serves
healthcare providers in more than 140 countries. Additional information
about Teleflex can be obtained from the company's website at teleflex.com.
Forward-Looking Statements
Any statements contained in this press release that do not describe
historical facts may constitute forward-looking statements. Any
forward-looking statements contained herein are based on our
management's current beliefs and expectations, but are subject to a
number of risks, uncertainties and changes in circumstances, which may
cause actual results or company actions to differ materially from what
is expressed or implied by these statements. These risks and
uncertainties are identified and described in more detail in our filings
with the Securities and Exchange Commission, including our Annual Report
on Form 10-K.
Teleflex, Arrow, Vascular Positioning System, VPS and VPS G4 are
trademarks or registered trademarks of Teleflex Incorporated or its
affiliates. © 2013 Teleflex Incorporated. All rights reserved. 2013-1992
Source: Teleflex Incorporated
Teleflex Incorporated
Jake Elguicze
Treasurer and Vice
President, Investor Relations
610-948-2836